Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registryAlberto Carmona‐Bayonas, Pilar Alfonso, Paula Jiménez‐Fonseca et al.|European Journal of Surgical Oncology|2018Cited by 60
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with CancerAlberto Carmona‐Bayonas, Javier Gállego, Paula Jiménez‐Fonseca et al.|Thrombosis and Haemostasis|2019Cited by 28
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Maria Belen Delany, Eudald Felip et al.|Therapeutic Advances in Medical Oncology|2021Cited by 7
Abstract P5-13-24: Efficacy of first line CDK4/6 inhibitors in HER2-low vs HER2-zero, hormone receptor positive, HER2 negative metastatic breast cancerRodrigo Sánchez-Bayona, Pablo Tolosa, Santiago Terán et al.|Cancer Research|2022Cited by 4
Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemicPablo Tolosa, Eva Ciruelos, Ana Sánchez et al.|Clinical Cancer Research|2020Cited by 2